VRE infections are treated with antibiotics such as daptomycin, linezolid, tigecycline, and sometimes ceftaroline or oritavancin, selected based on susceptibility testing and infection site.
Contents
- Can VRE be controlled with antibiotics?
- Is VRE resistant to all antibiotics?
- Which antibiotic is used to treat MRSA and VRE infections?
- Does doxycycline cover VRE?
- Does VRE ever go away?
- Should patients with VRE be isolated?
- Can I catch VRE?
- How do you stop VRE?
- Can you catch VRE from being in the same room?
- Is VRE a hospital acquired infection?
- How long can VRE live on surfaces?
- What antibiotic kills Enterococcus?
- Is VRE like MRSA?
- Is there a treatment for VRE?
- When do you treat VRE in urine?
Can VRE be controlled with antibiotics?
Yes, VRE infections can be controlled with specific non-vancomycin antibiotics once susceptibility is confirmed.
Treatment relies on agents like daptomycin, linezolid, or tigecycline that retain activity against vancomycin-resistant strains. The choice depends on the infection site, patient factors, and local resistance patterns. According to the CDC, infectious disease consultation is recommended for optimal antibiotic selection.
Is VRE resistant to all antibiotics?
No, VRE is not resistant to all antibiotics, though it resists vancomycin and often other common agents.
VRE remains susceptible to several newer antibiotics including daptomycin, linezolid, tigecycline, and ceftaroline. However, resistance to these agents can emerge during therapy, so susceptibility testing is essential. The NIH emphasizes that treatment options, while limited, do exist for most VRE infections.
Which antibiotic is used to treat MRSA and VRE infections?
No single antibiotic reliably treats both MRSA and VRE; vancomycin covers MRSA but not VRE, while daptomycin or linezolid can cover both.
Vancomycin remains first-line for MRSA but fails against VRE due to the vanA/vanB resistance genes. Daptomycin and linezolid have activity against both pathogens, making them useful when the causative organism is unknown. The Mayo Clinic notes that combination therapy may be needed for severe polymicrobial infections.
Does doxycycline cover VRE?
Doxycycline has variable activity against VRE and is generally not a first-line choice for systemic infections.
Some VRE strains show in vitro susceptibility to doxycycline, and it may be considered for uncomplicated VRE cystitis when oral therapy is preferred. However, resistance is common, and breakpoints for Enterococcus are not well established. The Infectious Diseases Society of America recommends susceptibility testing before using doxycycline for VRE.
Does VRE ever go away?
VRE colonization can persist for months to years, but active infections often resolve with appropriate antibiotic therapy.
Many patients remain colonized with VRE in the gastrointestinal tract long after infection clears, serving as reservoirs for transmission. Decolonization strategies are not routinely recommended. The CDC states that clearance of colonization is unpredictable and may occur spontaneously.
Should patients with VRE be isolated?
Yes, patients with VRE infection or colonization should be placed on contact precautions in healthcare settings.
Contact precautions include private rooms (or cohorting), gowns and gloves for all room entry, and dedicated equipment. These measures reduce transmission to other vulnerable patients. The CDC recommends continuing precautions for the duration of hospitalization.
Can I catch VRE?
Yes, VRE can be acquired through direct contact with contaminated surfaces or hands, though healthy people rarely develop illness.
Transmission occurs via the fecal-oral route or contaminated environmental surfaces, not through casual contact like hugging. Risk is highest in healthcare settings among patients with prolonged antibiotic exposure, invasive devices, or immunocompromise. The Mayo Clinic notes that community acquisition is uncommon but possible.
How do you stop VRE?
Stopping VRE spread requires hand hygiene, contact precautions, environmental cleaning, and antibiotic stewardship.
- Perform hand hygiene with soap and water or alcohol-based sanitizer before and after patient contact.
- Use EPA-registered disinfectants effective against Enterococcus on high-touch surfaces.
- Limit unnecessary antibiotic use, especially vancomycin and third-generation cephalosporins, which select for VRE.
The CDC identifies these as core prevention strategies in healthcare facilities.
Can you catch VRE from being in the same room?
No, VRE is not airborne; simply sharing a room poses minimal risk without direct contact with contaminated surfaces.
Transmission requires contact with contaminated hands, equipment, or environmental surfaces. Airborne spread does not occur. The WHO confirms that standard ventilation is sufficient; no special air handling is needed for VRE patients.
Is VRE a hospital acquired infection?
Yes, VRE is predominantly a healthcare-associated infection, though community-onset cases are increasingly recognized.
Hospitals, long-term care facilities, and dialysis centers are primary reservoirs due to high antibiotic pressure and vulnerable populations. The CDC classifies VRE among the top healthcare-associated pathogens, with most infections occurring in patients with recent healthcare exposure.
How long can VRE live on surfaces?
VRE can survive on dry environmental surfaces for 5 days to 4 months depending on conditions.
Studies show Enterococcus species persist on stainless steel, plastic, and fabric for weeks to months. Moisture, organic material, and temperature affect survival time. The NIH emphasizes that thorough terminal cleaning with sporicidal agents is critical after VRE patient discharge.
What antibiotic kills Enterococcus?
For susceptible Enterococcus, ampicillin is the drug of choice; for VRE, daptomycin, linezolid, or tigecycline are used based on susceptibility.
Ampicillin provides reliable bactericidal activity against Enterococcus faecalis and many E. faecium strains. Vancomycin is an alternative for penicillin-allergic patients if the isolate is susceptible. The IDSA guidelines recommend combination therapy for serious Enterococcal endocarditis.
Is VRE like MRSA?
VRE and MRSA are both multidrug-resistant Gram-positive cocci causing healthcare-associated infections, but they differ in species, resistance mechanisms, and treatment options.
MRSA is Staphylococcus aureus resistant to beta-lactams via mecA; VRE is Enterococcus resistant to vancomycin via van genes. Both spread via contact, but VRE colonizes the GI tract more persistently. The CDC tracks both as urgent antibiotic resistance threats requiring similar infection control measures.
Is there a treatment for VRE?
Yes, several antibiotics treat VRE infections including daptomycin, linezolid, tigecycline, ceftaroline, and oritavancin.
Treatment selection requires susceptibility testing, as resistance patterns vary by strain and geography. Newer agents like tedizolid and eravacycline show promise. The FDA has approved multiple agents specifically for VRE infections since 2010, expanding therapeutic options.
When do you treat VRE in urine?
Treat VRE bacteriuria only when symptomatic UTI is present; asymptomatic bacteriuria generally does not require treatment except in pregnancy or before urologic procedures.
Symptoms include dysuria, frequency, urgency, flank pain, or fever with pyuria. Overtreating asymptomatic colonization drives further resistance. The IDSA guidelines recommend against screening for or treating asymptomatic VRE bacteriuria in most patients.